Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/04/12 | 8-K | Current report filing |
|
6 | |
| 12/04/12 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
68 | |
| 11/15/12 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 11/05/12 | 8-K/A | Current report filing |
|
4 | |
| 11/02/12 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
6 | |
| 10/26/12 | UPLOAD | SEC-generated letter |
|
4 | |
| 10/24/12 | 8-K | Current report filing |
|
5 | |
| 10/24/12 | 8-K/A | Current report filing |
|
6 | |
| 10/24/12 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
4 | |
| 10/18/12 | 8-K | Current report filing |
|
5 |
